The data indicated that HCC patients with high STC1 expression had shorter median overall survival times than patients with low STC1 expression (19 months vs. 37 months, HR = 2.30, 95% CI 1.25–4.22, **P = 0.0051) (Fig. 6E). Here, STC1 is linked to hepatocellular carcinoma.